Tactile Systems Technology logo
Tactile Systems Technology TCMD
$ 27.4 -1.23%
report update icon

Annual report 2025
added 02-17-2026

Tactile Systems Technology Balance Sheet 2024-2011 | TCMD

Brief balance sheet overview of Tactile Systems Technology

The review uses the five latest available annual reports between 2021 and 2025.

Across five periods, assets reached $273.9 million versus $244.3 million initially. Growth of +12.1% reflects gradual development.

Liabilities grew more slowly than assets: -52.6% versus +12.1%. Expansion relied more on equity, improving funding quality.

Internal capital represents 79.9% of the balance sheet, previously 52.5%. This is a strong capital position.

Cash accounts for 30.5% of assets versus 11.6% initially. The change indicates the degree of financial flexibility.

Retained earnings reached $54.9 million, changing +566.3% over the period. A positive accumulated result supports equity.

Overall assessment

Tactile Systems Technology's financial position is positive on balance sheet evidence. Growth in resources has not undermined capital strength.

Annual Balance Sheet Tactile Systems Technology

2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

Net Debt

-75.4 M -39.8 M 1.44 M -2.37 M -26.5 M -6.18 M -20.1 M -24 M -30.7 M -7.06 M -5.4 M -6.52 M - -

Long Term Debt

- 16 M 18.4 M 20.9 M 23.4 M 19.4 M - - - - - 4 K 14 K - -

Long Term Debt Current

3.2 M 2.98 M 2.81 M 2.5 M 2.51 M 2.01 M 1.45 M - - - - - - - -

Total Non Current Liabilities

14.1 M 40.6 M 46.7 M 69.3 M 81.6 M 22.6 M 17.7 M 1.72 M 1.14 M 503 K 193 K 649 K 1.37 M - -

Total Current Liabilities

41 M 40.7 M 41.1 M 64.3 M 34.5 M 26.7 M 21.4 M 16.1 M 14.5 M 13.8 M - - - - -

Total Liabilities

55 M 81.3 M 87.8 M 134 M 116 M 49.3 M 39.2 M 17.8 M 15.7 M 14.3 M 9.7 M 6.84 M 7.02 M - -

Retained Earnings

54.9 M 35.9 M 18.9 M -9.62 M 8.24 M - 20.7 M 9.7 M 3.08 M -2.77 M -5.65 M -6.87 M -8.94 M - -

Total Assets

274 M 298 M 281 M 255 M 244 M 174 M 152 M 107 M 88.4 M 73.9 M 37 M 31.5 M 29.2 M - -

Cash and Cash Equivalents

83.4 M 94.4 M 61 M 21.9 M 28.2 M 47.9 M 22.8 M 20.1 M 24 M 30.7 M 7.06 M 5.42 M - - -

Book Value

219 M 217 M 194 M 121 M 128 M 125 M 113 M 89.3 M 72.8 M 59.6 M 27.3 M 24.7 M 22.2 M - -

Total Shareholders Equity

219 M 217 M 194 M 121 M 128 M 125 M 113 M 89.3 M 72.8 M 59.6 M -5.65 M -6.43 M - - -

All numbers in USD currency

Quarterly Balance Sheet Tactile Systems Technology

2025-Q3 2025-Q2 2025-Q1 2024-Q4 2024-Q3 2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

Long Term Debt

- 14.4 M 15.2 M 16 M 27 M 27.8 M 28.5 M 18.4 M 19 M 47.5 M 48.3 M 20.9 M 21.5 M - 22.7 M 23.4 M 23.4 M 18.5 M 18.9 M 19.4 M 19.4 M 19.4 M 19.4 M 15.1 M 15.1 M 15.1 M 15.1 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Total Non Current Liabilities

15 M 37.7 M 39.2 M 40.6 M 42.7 M 43.9 M 45.4 M 46.7 M 64.9 M 66.4 M 67.9 M 69.3 M 78.5 M - 77.8 M 81.6 M 86 M 22.3 M 22.2 M 22.6 M 22.6 M 22.6 M 22.6 M 17.7 M 17.7 M 17.7 M 17.7 M 1.72 M 1.72 M 1.72 M 1.72 M - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Total Liabilities

54.2 M 78.1 M 74.6 M 81.3 M 79.8 M 78.1 M 78.6 M 87.8 M 110 M 115 M 119 M 134 M 134 M - 118 M 116 M 117 M 48.9 M 50.2 M 49.3 M 49.3 M 49.3 M 49.3 M 39.2 M 39.2 M 39.2 M 39.2 M 17.8 M 17.8 M 17.8 M 17.8 M 15.7 M 15.7 M 15.7 M 15.7 M 14.3 M 14.3 M 14.3 M 14.3 M 9.7 M 9.7 M 9.7 M - - - - - - - - - - - - - - - - -

Retained Earnings

44.3 M 36.1 M 32.9 M 35.9 M 26.1 M 21 M 16.7 M 18.9 M 10.7 M -11.6 M -11.5 M -9.62 M -14.2 M - -7.32 M 8.24 M 15.7 M 19.1 M 17.8 M 20.1 M 20.1 M 20.1 M 20.1 M 20.7 M 20.7 M 20.7 M 20.7 M 9.7 M 9.7 M 9.7 M 9.7 M 3.08 M 3.08 M 3.08 M 3.08 M -2.77 M -2.77 M -2.77 M -2.77 M -5.65 M -5.65 M -5.65 M - - - - - - - - - - - - - - - - -

Total Assets

259 M 273 M 280 M 298 M 288 M 279 M 272 M 281 M 293 M 274 M 276 M 255 M 249 M - 233 M 244 M 249 M 182 M 175 M 174 M 174 M 174 M 174 M 152 M 152 M 152 M 152 M 107 M 107 M 107 M 107 M 88.4 M 88.4 M 88.4 M 88.4 M 73.9 M 73.9 M 73.9 M 73.9 M 37 M 37 M 37 M - - - - - - - - - - - - - - - - -

Cash and Cash Equivalents

66 M 81.5 M 83.6 M 94.4 M 82.1 M 73.6 M 60.7 M 61 M 66 M 63.2 M 55 M 21.9 M 23.4 M 23.4 M 21.2 M 28.2 M 22.4 M 49 M 46.9 M 47.9 M 47.9 M 47.9 M 47.9 M 22.8 M 22.8 M 22.8 M 22.8 M 22.8 M 20.1 M 20.1 M 20.1 M 24 M 24 M 24 M 24 M 30.7 M 30.7 M 30.7 M 30.7 M 7.06 M 7.06 M 7.06 M - 5.42 M - - - 6.54 M - - - - - - - - - - -

Book Value

205 M 195 M 206 M 217 M 208 M 201 M 193 M 194 M 183 M 159 M 156 M 121 M 114 M - 115 M 128 M 132 M 133 M 125 M 125 M 125 M 125 M 125 M 113 M 113 M 113 M 113 M 89.3 M 89.3 M 89.3 M 89.3 M 72.8 M 72.8 M 72.8 M 72.8 M 59.6 M 59.6 M 59.6 M 59.6 M 27.3 M 27.3 M 27.3 M - - - - - - - - - - - - - - - - -

Total Shareholders Equity

205 M 195 M 206 M 217 M 208 M 201 M 193 M 194 M 183 M 159 M 156 M 121 M 114 M 114 M 115 M 128 M 132 M 133 M 125 M 125 M 125 M 125 M 125 M 113 M 113 M 113 M 113 M 89.3 M 89.3 M 89.3 M 89.3 M 72.8 M 72.8 M 72.8 M 72.8 M 59.6 M 59.6 M 59.6 M 59.6 M -5.65 M -5.65 M -5.65 M - -6.43 M - - - -7.11 M - - - - - - - - - - -

All numbers in USD currency

Balance Sheet is a fundamental financial report of Tactile Systems Technology, providing a complete picture of the company’s financial position at a specific point in time. Unlike the income statement, which records the results of operations over a certain period, the balance sheet shows what assets the company owns, what liabilities it has to creditors, and what equity is available to the owners.

For an investor, the balance sheet is important because it allows assessing the company’s financial stability, understanding how much debt it carries, and how dependent it is on borrowed financing. It helps calculate key liquidity and leverage ratios. When analyzing, attention should be paid to the debt-to-equity ratio (Debt/Equity), the amount of cash on the balance sheet, and the ratio of current liabilities to liquid assets.

Features of balance sheet analysis
  • Vertical and horizontal analysis
    Vertical analysis shows the structure of the balance sheet as a percentage of total assets or liabilities, while horizontal analysis shows the dynamics of changes over multiple periods.
  • Asset quality
    It is important to evaluate not only the amount of assets but also their liquidity and realizability.
  • Accounting for off-balance sheet liabilities
    Some liabilities may not be directly reflected in the balance sheet, which requires additional attention.

Balance sheet of other industry stocks – Medical devices

Issuer Price % 24h Market Cap Country
Cutera Cutera
CUTR
- -10.19 % $ 1.99 M usaUSA
Myomo Myomo
MYO
$ 0.93 -3.11 % $ 38.9 M usaUSA
EDAP TMS S.A. EDAP TMS S.A.
EDAP
- - $ 162 M franceFrance
GenMark Diagnostics, Inc. GenMark Diagnostics, Inc.
GNMK
- - $ 1.77 B usaUSA
Avinger Avinger
AVGR
- -20.74 % $ 369 K usaUSA
Axonics Modulation Technologies Axonics Modulation Technologies
AXNX
- - $ 3.31 B usaUSA
Eargo Eargo
EAR
- - $ 10.2 M usaUSA
Lianluo Smart Limited Lianluo Smart Limited
LLIT
- 24.59 % $ 44.8 M chinaChina
Allied Healthcare Products Allied Healthcare Products
AHPI
- 3.58 % $ 2.21 M usaUSA
Obalon Therapeutics, Inc. Obalon Therapeutics, Inc.
OBLN
- -5.86 % $ 30.6 M usaUSA
Apollo Endosurgery Apollo Endosurgery
APEN
- - $ 475 M usaUSA
Aziyo Biologics Aziyo Biologics
AZYO
- 1.37 % $ 20.5 M usaUSA
BioSig Technologies BioSig Technologies
BSGM
- 37.08 % $ 85.7 M usaUSA
BIOLASE BIOLASE
BIOL
- -13.19 % $ 166 K usaUSA
Profound Medical Corp. Profound Medical Corp.
PROF
$ 7.24 -0.14 % $ 219 M canadaCanada
AxoGen AxoGen
AXGN
$ 41.37 0.53 % $ 1.91 B usaUSA
Quanterix Corporation Quanterix Corporation
QTRX
$ 3.38 -3.15 % $ 144 M usaUSA
AVITA Medical AVITA Medical
RCEL
$ 4.44 -3.69 % $ 124 M australiaAustralia
Conformis Conformis
CFMS
- - $ 16.4 M usaUSA
Cardiovascular Systems Cardiovascular Systems
CSII
- 0.15 % $ 844 M usaUSA
CryoLife, Inc. CryoLife, Inc.
CRY
- -4.14 % $ 702 M usaUSA
Bruker Corporation Bruker Corporation
BRKR
$ 61.74 -1.86 % $ 9.37 B usaUSA
CHF Solutions, Inc. CHF Solutions, Inc.
CHFS
- 1.15 % $ 34.5 M usaUSA
Smith & Nephew plc Smith & Nephew plc
SNN
$ 32.66 0.31 % $ 28.3 B britainBritain
Soliton, Inc. Soliton, Inc.
SOLY
- -1.42 % $ 435 M usaUSA
Hancock Jaffe Laboratories, Inc. Hancock Jaffe Laboratories, Inc.
HJLI
- -1.98 % $ 98.3 M usaUSA
Itamar Medical Ltd. Itamar Medical Ltd.
ITMR
- 0.03 % $ 1.58 B israelIsrael
Misonix, Inc. Misonix, Inc.
MSON
- - $ 462 M usaUSA
Neovasc Neovasc
NVCN
- - $ 111 M canadaCanada
Dynatronics Corporation Dynatronics Corporation
DYNT
- 14.99 % $ 929 K usaUSA
Tandem Diabetes Care Tandem Diabetes Care
TNDM
$ 18.59 4.67 % $ 1.26 B usaUSA
Intersect ENT, Inc. Intersect ENT, Inc.
XENT
- - $ 955 M usaUSA
Second Sight Medical Products Second Sight Medical Products
EYES
- -0.97 % $ 54.4 M usaUSA
GBS GBS
GBS
- -0.57 % $ 7.12 M usaUSA
ClearPoint Neuro ClearPoint Neuro
CLPT
$ 14.14 -2.68 % $ 400 M usaUSA
IRIDEX Corporation IRIDEX Corporation
IRIX
$ 0.86 -1.95 % $ 14.6 M usaUSA
Avanos Medical Avanos Medical
AVNS
$ 24.99 - $ 1.16 B usaUSA
Viemed Healthcare Viemed Healthcare
VMD
$ 11.65 -2.27 % $ 453 M usaUSA
Varex Imaging Corporation Varex Imaging Corporation
VREX
$ 10.95 -1.62 % $ 453 M usaUSA
Invacare Corporation Invacare Corporation
IVC
- - $ 24.7 M usaUSA
Cytosorbents Corporation Cytosorbents Corporation
CTSO
$ 0.35 -4.32 % $ 21.8 M usaUSA
LENSAR LENSAR
LNSR
$ 5.25 -1.87 % $ 62.8 M usaUSA
Beyond Air Beyond Air
XAIR
$ 5.51 0.92 % $ 45.7 B usaUSA
NanoVibronix NanoVibronix
NAOV
- - $ 1.08 M usaUSA
Xtant Medical Holdings Xtant Medical Holdings
XTNT
$ 0.43 0.14 % $ 60 M usaUSA
NuVasive NuVasive
NUVA
- - $ 2.07 B usaUSA
Natus Medical Incorporated Natus Medical Incorporated
NTUS
- 1.94 % $ 1.05 B usaUSA
Nevro Corp. Nevro Corp.
NVRO
- - $ 217 M usaUSA
Zimmer Biomet Holdings Zimmer Biomet Holdings
ZBH
$ 97.15 1.46 % $ 19.2 B usaUSA